Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy

Francesco Paolo Tambaro; Sajad Khazal; Cesar Nunez; Dristhi Ragoonanan; Priti Tewari; Demetrios Petropoulos; Partow Kebriaei; William George Wierda; Kris Michael Mahadeo

doi:10.1002/ccr3.2918

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy

Francesco Paolo Tambaro
, Sajad Khazal
, Cesar Nunez
, Dristhi Ragoonanan
, Priti Tewari
, Demetrios Petropoulos
, Partow Kebriaei
, William George Wierda
, Kris Michael Mahadeo

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1678-1681
Number of pages	4
Journal	Clinical Case Reports
Volume	8
Issue number	9
DOIs	https://doi.org/10.1002/ccr3.2918
State	Published - Sep 1 2020
Externally published	Yes

ASJC Scopus Subject Areas

General Medicine

Keywords

acute lymphoblastic leukemia
blinatumomab
chimeric antigen receptor

Access to Document

10.1002/ccr3.2918

OpenUrl availability

Full text

Cite this

@article{5e2e56df6268460c97b69c5a084b8cee,

title = "Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy",

keywords = "acute lymphoblastic leukemia, blinatumomab, chimeric antigen receptor",

author = "Tambaro, \{Francesco Paolo\} and Sajad Khazal and Cesar Nunez and Dristhi Ragoonanan and Priti Tewari and Demetrios Petropoulos and Partow Kebriaei and Wierda, \{William George\} and Mahadeo, \{Kris Michael\}",

note = "{\textcopyright} 2020 The Authors. Clinical Case Reports published by John Wiley \& Sons Ltd.",

year = "2020",

month = sep,

day = "1",

doi = "10.1002/ccr3.2918",

language = "English",

volume = "8",

pages = "1678--1681",

journal = "Clinical Case Reports",

issn = "2050-0904",

number = "9",

}

TY - JOUR

T1 - Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy

AU - Tambaro, Francesco Paolo

AU - Khazal, Sajad

AU - Nunez, Cesar

AU - Ragoonanan, Dristhi

AU - Tewari, Priti

AU - Petropoulos, Demetrios

AU - Kebriaei, Partow

AU - Wierda, William George

AU - Mahadeo, Kris Michael

PY - 2020/9/1

Y1 - 2020/9/1

KW - acute lymphoblastic leukemia

KW - blinatumomab

KW - chimeric antigen receptor

UR - https://www.scopus.com/pages/publications/85085564192

UR - https://www.scopus.com/pages/publications/85085564192#tab=citedBy

UR - https://www.mendeley.com/catalogue/15b654df-d903-3051-8741-39e4aec0ee79/

U2 - 10.1002/ccr3.2918

DO - 10.1002/ccr3.2918

M3 - Article

C2 - 32983475

AN - SCOPUS:85085564192

SN - 2050-0904

VL - 8

SP - 1678

EP - 1681

JO - Clinical Case Reports

JF - Clinical Case Reports

IS - 9

ER -

Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy

ASJC Scopus Subject Areas

Keywords

Access to Document

OpenUrl availability

Other files and links

Cite this